Long-term Efficacy and Safety of Up to 108 Weeks of Ixekizumab in Pediatric Patients With Moderate to Severe Plaque Psoriasis-Reference-Cited by-同舟云学术

Long-term Efficacy and Safety of Up to 108 Weeks of Ixekizumab in Pediatric Patients With Moderate to Severe Plaque Psoriasis

Published:2022-05-01 Issue:5 Volume:158 Page:533
ISSN:2168-6068
Container-title:JAMA Dermatology
language:en
Short-container-title:JAMA Dermatol

Author:

Paller Amy S.¹²,Seyger Marieke M. B.³,Magariños Gabriel A.⁴,Pinter Andreas⁵,Cather Jennifer C.⁶,Rodriguez-Capriles Claudia⁷,Zhu Danting⁷,Somani Najwa⁷,Garrelts Alyssa⁷,Papp Kim A.⁸,Magariños Gabriel A.⁹,Galimberti Ricardo⁹,Viola Diego⁹,Luna Paula⁹,Lynde Charles⁹,Marcoux Danielle⁹,Prajapati Vimal⁹,Cy Ajith⁹,Arenberger Petr⁹,Polaskova Stanislava⁹,Buckova Hans⁹,Bartonova Jirina⁹,Cetkovska Petra⁹,Hercogova Jana⁹,Lacour Jean-Philippe⁹,Phan Alice⁹,Sticherling Michael⁹,Staubach-Renz Petra⁹,Simon Margrit⁹,Pinter Andreas⁹,Magnolo Nina⁹,Dosa Piroska⁹,Noll Judit⁹,Remenyik Eva⁹,Kemeny Lajos⁹,Bakos Noemi⁹,Bernabe del Rio Claudia⁹,Toledo-Bahena Mirna⁹,Gomez Flores Minerva⁹,Barragan Estudillo Zamira⁹,Seyger Marieke⁹,Weglowska Jolanta⁹,Szymanska Elzbieta⁹,Kaszuba Andrzej⁹,Murashkin Nikolay⁹,Vicente Villa Asuncion⁹,Laguna Raul L.⁹,Rivera Diaz Raquel⁹,Bagel Jerry⁹,Browning John⁹,Bukhalo Michael⁹,Cather Jennifer⁹,Cruz Santana Alma⁹,Elewski Boni⁹,Forman Seth⁹,Gonzalez-Chavez Jose⁹,Gottlieb Scott⁹,Hake Harris Holly⁹,Kaffenberger Jessica⁹,Kwong Pearl⁹,Leitenberger Sabre⁹,Lugo-Somolinos Aida⁹,Kirkorian Anna⁹,Martin Kari⁹,Paller Amy⁹,Pariser David⁹,Rich Phoebe⁹,Rosenblatt Adena⁹,Seminario-Vidal Lucia⁹,Siegfried Elaine⁹,Travers Jeffrey⁹,Vendrell-Benito Pedro⁹,Weisman Jamie⁹,Wine Lee Lara⁹,Zook Matthew⁹,Sanches-Rivera Samuel⁹,Laquer Vivian⁹,

Affiliation:

1. Department of Dermatology, Northwestern University Feinberg School of Medicine, Chicago, Illinois

2. Department of Pediatrics, Northwestern University Feinberg School of Medicine, Chicago, Illinois

3. Department of Dermatology, Radboud University Medical Center, Nijmegen, the Netherlands

4. Psoriahue, Buenos Aires, Argentina

5. Department of Dermatology, Venereology and Allergology, University Hospital Frankfurt, Frankfurt am Main, Germany

6. Mindful Dermatology and Modern Research Associates, Dallas, Texas

7. Eli Lilly and Company, Indianapolis, Indiana

8. K Papp Clinical Research and Probity Medical Research, Waterloo, Ontario, Canada

9. for the IXORA-PEDS Investigators

Publisher

American Medical Association (AMA)

Subject

Dermatology

Link

https://jamanetwork.com/journals/jamadermatology/articlepdf/2790783/jamadermatology_paller_2022_oi_220013_1652203149.5547.pdf

Reference24 articles.

1. Efficacy and safety of ixekizumab in a phase III, randomized, double-blind, placebo-controlled study in paediatric patients with moderate-to-severe plaque psoriasis (IXORA-PEDS).;Paller;Br J Dermatol,2020

2. Systemic treatment of pediatric psoriasis: a review.;Napolitano;Dermatol Ther (Heidelb),2016

3. Epidemiology and comorbidity of psoriasis in children.;Augustin;Br J Dermatol,2010

4. Biologicals for moderate-to-severe plaque type psoriasis in pediatric patients.;Libon;Expert Rev Clin Immunol,2021

5. Quality of life and clinical features in Swedish children with psoriasis.;Gånemo;Pediatr Dermatol,2011

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biologics and Small Molecule Targeted Therapies for Pediatric Alopecia Areata, Psoriasis, Atopic Dermatitis, and Hidradenitis Suppurativa in the US: A Narrative Review;Children;2024-07-25

2. Novel therapies in juvenile idiopathic arthritis;Current Opinion in Rheumatology;2024-05-23

3. Unveiling the impact of itch, pain, fatigue and disease severity in paediatric patients with psoriasis and the influence of methotrexate and biologics;Journal of the European Academy of Dermatology and Venereology;2024-03-07

4. Satisfaction with the Injection Experience of a New, Citrate-Free Formulation of Ixekizumab;Advances in Therapy;2024-03-05

5. A Practical Guide to Using Biologics in Pediatric Dermatology;Journal of Cutaneous Medicine and Surgery;2024-01